For Speedy Launch:


Nowadays, the U.S. Food and Drug Administration accredited the 1st COVID-19 vaccine. The vaccine has been acknowledged as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the avoidance of COVID-19 illness in people today 16 many years of age and more mature. The vaccine also carries on to be out there beneath emergency use authorization (EUA), like for people today twelve through fifteen many years of age and for the administration of a third dose in specific immunocompromised people today.

“The FDA’s approval of this vaccine is a milestone as we continue to battle the COVID-19 pandemic. While this and other vaccines have satisfied the FDA’s arduous, scientific standards for emergency use authorization, as the 1st Food and drug administration-accredited COVID-19 vaccine, the general public can be pretty confident that this vaccine fulfills the high standards for basic safety, success, and manufacturing excellent the Food and drug administration needs of an accredited products,” stated Performing Food and drug administration Commissioner Janet Woodcock, M.D. “While hundreds of thousands of people today have previously safely been given COVID-19 vaccines, we recognize that for some, the Food and drug administration approval of a vaccine could now instill additional self-confidence to get vaccinated. Today’s milestone places us one particular step closer to altering the training course of this pandemic in the U.S.” 

Given that Dec. eleven, 2020, the Pfizer-BioNTech COVID-19 Vaccine has been out there beneath EUA in people today 16 many years of age and more mature, and the authorization was expanded to include those people twelve through fifteen many years of age on Could 10, 2021. EUAs can be used by the Food and drug administration all through general public health and fitness emergencies to deliver obtain to professional medical items that could be successful in avoiding, diagnosing, or treating a illness, provided that the Food and drug administration decides that the acknowledged and likely advantages of a products, when used to prevent, diagnose, or take care of the illness, outweigh the acknowledged and likely dangers of the products.

Food and drug administration-accredited vaccines go through the agency’s normal system for reviewing the excellent, basic safety and success of professional medical items. For all vaccines, the Food and drug administration evaluates knowledge and information and facts bundled in the manufacturer’s submission of a biologics license application (BLA). A BLA is a extensive document that is submitted to the agency giving pretty precise demands. For Comirnaty, the BLA builds on the intensive knowledge and information and facts formerly submitted that supported the EUA, these as preclinical and clinical knowledge and information and facts, as nicely as details of the manufacturing system, vaccine screening outcomes to ensure vaccine excellent, and inspections of the web sites exactly where the vaccine is manufactured. The agency conducts its individual analyses of the information and facts in the BLA to make confident the vaccine is safe and sound and successful and fulfills the FDA’s standards for approval. 

Comirnaty includes messenger RNA (mRNA), a variety of genetic materials. The mRNA is used by the entire body to make a mimic of one particular of the proteins in the virus that will cause COVID-19. The consequence of a individual getting this vaccine is that their immune process will ultimately respond defensively to the virus that will cause COVID-19. The mRNA in Comirnaty is only present in the entire body for a small time and is not integrated into – nor does it alter – an individual’s genetic materials. Comirnaty has the similar formulation as the EUA vaccine and is administered as a collection of two doses, 3 weeks apart. 

“Our scientific and professional medical gurus conducted an incredibly complete and thoughtful analysis of this vaccine. We evaluated scientific knowledge and information and facts bundled in hundreds of 1000’s of internet pages, conducted our individual analyses of Comirnaty’s basic safety and success, and carried out a specific assessment of the manufacturing processes, like inspections of the manufacturing facilities,” stated Peter Marks, M.D., Ph.D., director of FDA’s Heart for Biologics Analysis and Exploration. “We have not misplaced sight that the COVID-19 general public health and fitness crisis carries on in the U.S. and that the general public is counting on safe and sound and successful vaccines. The general public and professional medical neighborhood can be confident that despite the fact that we accredited this vaccine expeditiously, it was thoroughly in holding with our existing high standards for vaccines in the U.S.”

Food and drug administration Analysis of Safety and Effectiveness Knowledge for Approval for 16 Decades of Age and Older

The 1st EUA, issued Dec. eleven, for the Pfizer-BioNTech COVID-19 Vaccine for people today 16 many years of age and more mature was based mostly on basic safety and success knowledge from a randomized, controlled, blinded ongoing clinical trial of 1000’s of people today. 

To assistance the FDA’s approval determination these days, the Food and drug administration reviewed updated knowledge from the clinical trial which supported the EUA and bundled a extended period of stick to-up in a bigger clinical trial inhabitants. 

Specifically, in the FDA’s assessment for approval, the agency analyzed success knowledge from around twenty,000 vaccine and twenty,000 placebo recipients ages 16 and more mature who did not have evidence of the COVID-19 virus an infection inside of a 7 days of getting the next dose. The basic safety of Comirnaty was evaluated in around 22,000 people today who been given the vaccine and 22,000 people today who been given a placebo 16 many years of age and more mature.

Dependent on outcomes from the clinical trial, the vaccine was 91% successful in avoiding COVID-19 illness. 

Far more than 50 % of the clinical trial individuals were being followed for basic safety outcomes for at least 4 months soon after the next dose. All round, around twelve,000 recipients have been followed for at least 6 months.

The most generally noted facet consequences by those people clinical trial individuals who been given Comirnaty were being soreness, redness and inflammation at the injection internet site, exhaustion, headache, muscle mass or joint soreness, chills, and fever. The vaccine is successful in avoiding COVID-19 and likely really serious outcomes like hospitalization and death.

Furthermore, the Food and drug administration conducted a arduous analysis of the write-up-authorization basic safety surveillance knowledge pertaining to myocarditis and pericarditis following administration of the Pfizer-BioNTech COVID-19 Vaccine and has decided that the knowledge reveal improved dangers, specially inside of the seven days following the next dose. The noticed possibility is greater among the males beneath forty many years of age in contrast to girls and more mature males. The noticed possibility is maximum in males twelve through seventeen many years of age. Offered knowledge from small-term stick to-up advise that most people today have experienced resolution of signs. Having said that, some people today expected intense treatment assistance. Facts is not yet out there about likely long-term health and fitness outcomes. The Comirnaty Prescribing Facts involves a warning about these dangers.

Ongoing Safety Monitoring

The Food and drug administration and Centers for Disorder Handle and Prevention have checking programs in location to ensure that any basic safety issues continue to be identified and evaluated in a timely way. In addition, the Food and drug administration is necessitating the company to conduct postmarketing studies to more evaluate the dangers of myocarditis and pericarditis following vaccination with Comirnaty. These studies will include an analysis of long-term outcomes among the people today who establish myocarditis following vaccination with Comirnaty. In addition, despite the fact that not Food and drug administration demands, the company has committed to additional write-up-promoting basic safety studies, like conducting a being pregnant registry analyze to assess being pregnant and infant outcomes soon after receipt of Comirnaty all through being pregnant.

The Food and drug administration granted this application Priority Review. The approval was granted to BioNTech Manufacturing GmbH.

Connected Facts



The Food and drug administration, an agency inside of the U.S. Department of Overall health and Human Solutions, protects the general public health and fitness by assuring the basic safety, success, and security of human and veterinary medicines, vaccines and other biological items for human use, and professional medical units. The agency also is responsible for the basic safety and security of our nation’s foodstuff supply, cosmetics, nutritional health supplements, items that give off digital radiation, and for regulating tobacco items.